U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
CERTOPARIN
V72OT3K19I
Possibly Marketed Outside US
General
Record Details
Names
1
Identifiers
6
Display Structure
Relationships
1
Modifications
1
Characteristic Attributes
4
CERTOPARIN
V72OT3K19I
Possibly Marketed Outside US
General
Approval Year
Unknown
149,124
Record Details
Substance Class
Polymer
Record UNII
V72OT3K19I
Record Status
Validated (UNII)
Record Version
5
4
3
2
1
Names
1
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
CERTOPARIN
Preferred Name
English
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
MESH
C403769
PRIMARY
DRUG BANK
DB01109
PRIMARY
RXCUI
152610
PRIMARY
RxNorm
CHEBI
28304
PRIMARY
FDA UNII
V72OT3K19I
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Display Structure
Export Data
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
N816FF9P2W
CERTOPARIN SODIUM
SALT/SOLVATE -> PARENT
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Modifications
1
Agent Modifications
Show
5
20
100
All
entries
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
FORMATION OF LOW MW HEPARIN
DEPOLYMERIZATION
HYDROLYSIS AND OXIDATION
ISOPENTYL NITRITE
5N0U5TUC9Z
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
4
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
ANTI XA ACTIVITY
ENZYMATIC
INHIBITION PER MG 100 IU/MG (average) [80 to 120] (limits)
MOL_WEIGHT:WEIGHT AVERAGE
CHEMICAL
WEIGHT AVERAGE 5200 Da (average) [4200 to 6200] (limits)
ANTI IIA
ENZYMATIC
INHIBITION PER MG 32.5 IU/MG (average) [30 to 35] (limits)
DEGREE OF SULFATION
PHYSICAL
PER DISACCHARIDE 2.25 (average) [2 to 2.5] (limits)
Showing 1 to 4 of 4 entries
Previous
1
Next
